help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on October 4, 2006
Molecular Endocrinology, doi:10.1210/me.2006-0245
A more recent version of this article appeared on January 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
21/1/172    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Duval, D. L.
Right arrow Articles by Gutierrez-Hartmann, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duval, D. L.
Right arrow Articles by Gutierrez-Hartmann, A.

Submitted on June 12, 2006
Accepted on September 25, 2006

Differential Utilization of Transcription Activation Subdomains by Distinct Coactivators Regulates Pit-1 Basal and Ras Responsiveness

Dawn L. Duval, Matthew D. Jonsen, Scott E. Diamond, Patience Murapa, Annie Jean, and Arthur Gutierrez-Hartmann*

Departments of Medicine, Biochemistry and Molecular Genetics, and Clinical Pharmacy, University of Colorado HSC, Aurora, CO 80045; Department of Physiology, University of Kentucky College of Medicine, Lexington, KY 40536

* To whom correspondence should be addressed. E-mail: a.gutierrez-hartmann{at}uchsc.edu.

The POU-homeodomain transcription factor Pit-1 governs ontogeny and cell-specific gene expression of pituitary lactotropes, somatotropes and thyrotropes. The splice isoform, Pit-1{beta}, inserts a 26-amino acid (AA) repressor at AA48 in the Pit-1 transcription activation domain (TAD). The Pit-1 TAD contains a basal regulatory subregion, R1 (AA1-45) and a basal and Ras responsive region, R2 (AA46-80). To precisely map these activities, we generated GAL4-Pit-1/Pit-1{beta}TAD fusions and, in full-length HA-Pit-1, a series of substitution mutants of R2. Analysis in GH4 cells identified an activation domain at AA50-70, followed by an overlapping, dual-function, Ras-responsive-inhibitory domain, located from AA60-80. In contrast, GAL4-Pit-1{beta}TAD repressed both basal and Ras-mediated TAD activity. To determine the functional interplay between TAD subregions and the {beta}-domain, we inserted the {beta}-domain every 10-AA across the 80-AA Pit-1 TAD. Like wildtype Pit-1{beta}, each construct retained transcriptional activity in HeLa cells and repressed the Ras response in GH4 cells. However, {beta}-domain insertion at AA61 and AA71 resulted in greater repression of Ras responsiveness, defining a critical R2 TAD spanning AA61-71 of Pit-1. Furthermore, Ras activation is augmented by Steroid receptor coactivator 1, whereas CBP is not a Ras mediator in this system. In summary, the Pit-1/Pit-1{beta} TADs are comprised of multiple, modular and transferable subdomains, including a regulatory R1 domain, a basal activation region, a selective inhibitory-Ras responsive segment and a {beta}-specific repressor domain. These data provide novel insights into the mechanisms by which the Pit-1 TAD integrates DNA binding, protein partner interactions, and distinct signaling pathways to fine-tune Pit-1 activity.


Key words: Pituitary • Pit-1 • Prolactin • Transcriptional Activation Domain • Ras







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society